banner-img1.jpg
banner-img1.jpg
banner-img1.jpg
banner-img1.jpg

People,

Partners, Purpose, and Progress

Annual Report & Accounts 2019

Download Annual Report
Financial Highlights
Group operating profit $158.4m +7%
Proposed dividend 16.80c +5%
Adjusted profit before tax $150.3m +8%
Adjusted net operating margin 14.2% +110bps
Adjusted diluted EPS 48.44c +5%

Who are we

We are a global leader in healthcare advisory, communications, commercial, clinical and packaging services.

We are 8,700 people operating in 26 countries, across two divisions.

We are united by our purpose to partner with clients to deliver innovative healthcare solutions that improve patients’ lives.

Our core values, unique culture and robust business model enable us to deliver our strategy and build a sustainable organisation for the benefit of all our stakeholders.

UDG Healthcare plc is listed on the London Stock Exchange.

Our global divisions

logo

A global leader in healthcare advisory, communications, commercial and clinical services.

Services

Advisory

Healthcare brand advisory, strategic consulting, product commercialisation strategy, market access, analytics and commercial audit services.

Communications

Scientific and creative communications, digital and patient-centred content for medical affairs and brand commercialisation with areas of specialty including behavioural science, rare disease, PR and on-demand advertising services.

Commercial & Clinical

Commercialisation and clinical services including sales representatives, patient support and adherence services, contact centres, medical affairs and meetings and events.

68% of Group Operating Profit
14.4% Net operating margin
logo

A global leader in contract packaging, clinical, manufacturing and technology services.

Services

Packaging

Commercial packaging solutions in multiple formats including bottles, blisters, specialty and secondary packaging of injectables.

Clinical

A comprehensive and integrated clinical trial supply and management service, from pre-clinical through to commercialisation.

Manufacturing

Clinical manufacturing services including analytical services, formulation development, over-encapsulation and placebo manufacture.

Technology

Technology services to support both commercial and clinical packaging including design, serialisation solutions and clinical IRT.

32% of Group Operating Profit
13.9% Net operating margin